Brochure
28 Mar 2019
Interview by Newsweek, Time to Talk
PDF 272 kB
Interviewee：Dr. Steve J. P. Hsu (President of Genovior Biotech)
Content provided by our supplier
GENOVIOR BIOTECH CORPORATION
-
TW -
2016On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Other Content from GENOVIOR BIOTECH CORPORATION (8)
-
Video COMPANY PRESENTATION
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs
Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate
-
Brochure
CDMO
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance